⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CORT News
Corcept Therapeutics Inc.
Pomerantz LLP Calls Attention to Class Action Against Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
Pomerantz LLP Alerts Shareholders to Investor Suit Involving Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
prnewswire.com
CORT
Pomerantz LLP Alerts Shareholders to Investor Suit Involving Corcept Therapeutics Incorporated – CORT
accessnewswire.com
CORT
DEADLINE ALERT for PYPL, SMR, CORT, NAVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
globenewswire.com
PYPL
SMR
CORT
NAVN
DEADLINE ALERT for PYPL, SMR, CORT, NAVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
globenewswire.com
CORT
NAVN
PYPL
SMR
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
CORT
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
CORT
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
globenewswire.com
CORT
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
globenewswire.com
CORT